Peptide-Guided Nanoparticle Drug Delivery for Cardiomyocytes.
Dong LiAustin TaylorHaiwang ShiFang ZhouPengsheng LiJyotsna JoshiWuqiang ZhuShu WangPublished in: Biology (2024)
Biocompatible and safe CTP-NP3 can target the heart via binding to cardiomyocytes. This approach of targeting specific molecules-coated NPs may help in delivering therapeutic compounds to cardiomyocytes for the treatment of heart diseases with high efficacy and low toxicity to other tissues.